MedTrace Logo

Same Day Oral EC and Implant Initiation

NCT04678817 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 306

Last updated 2025-04-15

Study results available
· View outcomes & findings →

Summary

This is a study for clients presenting for emergency contraception (EC). EC is used to prevent pregnancy after unprotected intercourse. Clients presenting for EC may be offered either the copper or hormonal IUD or oral EC. Current guidelines allow for same-day implant initiation at the time of an EC encounter, as long as oral LNG EC is co-administered. This study will look at pregnancy rates and clients willingness to receive same-day implant + oral EC and same-day IUDs.

Conditions

  • Contraception

Interventions

DEVICE

Etonogestrel contraceptive implant with oral levonorgestrel

Participants who present for emergency contraception and select the Etonogestrel contraceptive implant with oral levonorgestrel

DEVICE

Levonorgestrel intrauterine device

Participants who present for emergency contraception and select the Levonorgestrel intrauterine device

DEVICE

Copper T380A intrauterine device

Participants who present for emergency contraception and select the Copper T380A intrauterine device

Sponsors & Collaborators

Principal Investigators

  • Lori Gawron, MD · University of Utah

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-17
Primary Completion
2023-04-27
Completion
2024-03-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04678817 on ClinicalTrials.gov